IPS examines PEPFAR guidance on family planning in light of new AIDS blueprint

Noting the U.S. government on Thursday "unveiled a major new strategy for pushing towards achieving an 'AIDS-free generation,'" Inter Press Service writes, "The far-reaching new blueprint for what's known as the President's Emergency Plan for AIDS Relief (PEPFAR) is being widely lauded, yet little attention has been given to a document, published in October, that stipulates how new PEPFAR funding can be used." The news service notes, "[a]ccording to that guidance, 'PEPFAR funds may not be used to purchase family planning commodities.'" "The language in the guidance was put there to make clear what exactly (PEPFAR) could and couldn't pay for -- that's problematic,' Mary Beth Hastings with the Center for Health and Gender Equity, a Washington advocacy group, told IPS," the news service writes. An unnamed spokesperson from PEPFAR "told IPS ... that 'there are other entities, particularly USAID, that meet that need [for family planning]. We're very interested in integrating our services,'" the news service writes (Biron, 11/29).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects